GeorgeKurdgelashviliMD(He/Him)

Internal Medicine • Oklahoma City, OK

Hospital Medicine/Hospitalist, Infectious Disease

Chief of Medicine Oklahoma City VA Healthcare System Clinical Professor, Dept of Medicine, University of Oklahoma College of Medicine

Join to view full profile

Dr. Kurdgelashvili is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kurdgelashvili's full profile

Already have an account?

Office
921 NE 13th street 111 C
Oklahoma City, OK 73104
Phone+1 405-456-1000

Education & Training

University of Oklahoma Health Sciences CenterFellowship, Infectious Disease, 2002 - 2004
Emory University School of MedicineResidency, Internal Medicine, 1999 - 2002
Tbilisi State Medical UniversityClass of 1996

Certifications & Licensure

OK State Medical License 2002 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Clinical Trials

VA CoronavirUs Research and Efficacy Studies-1 Start of enrollment: 2020 Nov 16
Terminated
Phase 3
Optimal Treatment for Recurrent Clostridium Difficile Start of enrollment: 2015 Dec 21
Recruiting
Phase 4
Roles: Contact
Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics Start of enrollment: 2018 Jan 22
Recruiting
Phase 4
Roles: Contact

Publications & Presentations

PubMed

4 citations
Early Telephone Appointments and Home Telehealth Monitoring May Improve 30-Day Readmission Rates in the COVID-19 Era.
Mohamad Khattab, Arleen Ramirez Jimenez, Mahmood Khattab, Isma Javed, Christopher Aston
American Journal of Medical Quality. 2021-01-01
11 citations
Case-control study of statin prevention of mould infections.
Jessica N. Thompson, Mark M. Huycke, Ronald A. Greenfield, George Kurdgelashvili, Chris A. Gentry
Mycoses. 2011-09-01
11 citations
Characteristics and outcomes of US Veterans at least 65 years of age at high risk of severe SARS-CoV-2 infection with or without receipt of oral antiviral agents.
Chris A Gentry, Phoi Nguyen, Sharanjeet K Thind, George Kurdgelashvili, Riley J Williams
The Journal of Infection. 2023-03-01

Press Mentions

HPV-related cancers rose before vaccines hit marketApril 27th, 2022